Management of gestational diabetes can be more efficient with the use continuous glucose monitoring (CGM), according to new research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...

Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device developer Masimo ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...

IRVINE, Calif., February 17, 2026--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement ...

WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo ...

・Masimo is undergoing an organizational realignment to sharpen its focus on core healthcare offerings. ・A U.S. jury ordered Apple to pay Masimo $634 million in damages in the patent infringement case; ...

A little more than a year after its high-profile proxy battle, Masimo has agreed to be acquired by Danaher in a cash deal valued at $9.9 billion. Danaher has agreed to pay $180 per share in cash for ...

Danaher could announce Masimo acquisition as early as Tuesday, FT reports Danaher valued at over $150 billion, Masimo at $7 billion Danaher previously acquired Abcam for $5.7 billion in 2023 Danaher ...

(Bloomberg) -- Danaher Corp. is nearing a roughly $10 billion deal to acquire US medical technology firm Masimo Corp., the Financial Times reported, citing unidentified people familiar with the matter ...

Danaher said it will pay $180 per share in cash for Masimo, a nearly 40% premium to where the stock closed Friday, confirming an earlier report by The Wall Street Journal.